Skip to content

Clinical trials

Terminated Triple Negative Breast Neoplasms trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Status: Terminated Country / region: Spain Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20152
20162
20175
20184
20196
20206
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Genmab2
AVEO Pharmaceuticals, Inc.1
AbbVie1
Amgen1
Ayala Pharmaceuticals, Inc,1
BerGenBio ASA1
Calithera Biosciences, Inc1
EMD Serono Research & Development Institute, Inc.1
ERYtech Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms28
Carcinoma, Non-Small-Cell Lung12
Squamous Cell Carcinoma of Head and Neck8
Carcinoma, Renal Cell5
Ovarian Neoplasms5
Breast Neoplasms4
Melanoma4
Colorectal Neoplasms3
Stomach Neoplasms3
Urinary Bladder Neoplasms3

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.